NIFK enhances the metastatic ability of lung cancer cells via the Runx-1-dependent repression of CK1α expression and activates TCF/β–catenin signaling, thereby promoting metastasis in lung cancer. This evidence concerns the gene RUNX1 and lung carcinoma.